Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,051.80 INR | +3.79% |
|
-14.11% | +6.95% |
Jan. 23 | Alivus Life Sciences Limited, Q3 2025 Earnings Call, Jan 23, 2025 | |
Jan. 23 | India's Alivus Life posts bigger Q3 profit on API boost | RE |
Chart calendar Alivus Life Sciences Limited
Upcoming events on Alivus Life Sciences Limited
Past events on Alivus Life Sciences Limited
2025-02-09 | Investor Meeting - Baroda BNP |
2025-02-04 | Investor Meeting - Catamaran |
2025-02-02 | Investor Meeting - Unique AMC |
2025-01-23 05:30 am | Q3 2025 Earnings Call |
2025-01-23 03:53 am | Q3 2025 Earnings Release |
2024-11-27 | Investor Meeting - Bajaj AMC |
2024-11-27 | Investor Meeting - Buoyant Capital |
2024-11-27 | Investor Meeting - Star Union Dai-ichi Life Insurance |
2024-11-26 | Investor Meeting - Tata Asset Management |
2024-10-30 | Investor Meeting - Julius Baer |
2024-10-29 | Investor Meeting - Kotak Securities |
2024-10-24 11:00 pm | Q2 2025 Earnings Call |
2024-10-24 08:57 am | Q2 2025 Earnings Release |
2024-09-25 05:30 am | Annual General Meeting |
2024-09-22 | DAM Capital Pharmaceutical Investor Conference |
2024-09-18 | Kotak Healthcare Forum |
2024-09-08 | Investor Meeting - Old Bridge Capital |
2024-09-05 | Investor Meeting - Helios Capital |
2024-09-04 | Investor Meeting - Equimark LLP |
2024-09-03 | Investor Meeting - Laburnum Capital |
Past dividends on Alivus Life Sciences Limited
2023-10-16 | Interim Payment 22.5 INR |
2023-03-23 | Interim Payment 21 INR |
2022-09-14 | Final Payment 10.5 INR |
2021-11-21 | Interim Payment 10.5 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 21 379 21 326 0.25% | 21 612 20 860 3.61% | 22 832 23 913 -4.52% | 23 949 | 28 231 | 32 137 |
EBITDA Million INR | Released Forecast Spread | 6 308 6 205 1.66% | 6 423 5 875 9.33% | 6 742 7 353 -8.31% | 6 749 | 8 521 | 9 860 |
EBIT Million INR | Released Forecast Spread | 5 929 5 790 2.4% | 6 002 5 514 8.85% | 6 208 6 999 -11.3% | 6 214 | 8 010 | 9 378 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 5 649 5 611 0.68% | 6 286 5 749 9.35% | 6 313 7 057 -10.54% | 6 370 | 8 129 | 9 557 |
Net income Million INR | Released Forecast Spread | 4 187 4 132 1.33% | 4 670 4 264 9.51% | 4 709 5 213 -9.66% | 4 784 | 6 501 | 8 031 |
EPS INR | Released Forecast Spread | 35,6 33,7 5.71% | 38,1 34,8 9.61% | 38,4 42,5 -9.63% | 39,1 | 48,1 | 54,2 |
Announcement Date | 20/04/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 5 093 5 275 -3.45% | 5 407 5 268 2.64% | 6 213 5 486 13.26% | 5 785 5 842 -0.98% | 5 954 5 980 -0.44% | 5 728 6 025 -4.93% | 5 366 6 071 -11.61% | 5 886 5 760 2.19% | 5 781 | 6 189 |
EBITDA Million INR | Released Forecast Spread | 1 436 1 446 -0.66% | 1 455 1 467 -0.85% | 2 064 1 536 34.39% | 1 932 1 705 13.29% | 1 671 2 012 -16.96% | 1 726 1 693 1.92% | 1 414 1 702 -16.87% | 1 595 1 736 -8.13% | 1 719 | 1 744 |
EBIT Million INR | Released Forecast Spread | 1 437 1 588 -9.49% | 1 413 1 528 -7.55% | 1 949 1 503 29.66% | 1 824 1 643 11% | 1 593 1 947 -18.17% | 1 269 1 708 -25.7% | 1 451 1 432 1.33% | 1 618 | 1 627 | |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 820 1 580 15.19% | 1 297 1 729 -25% | 1 502 1 464 2.62% | 1 645 | 1 654 | |||||
Net income Million INR | Released Forecast Spread | 1 069 1 039 2.87% | 1 050 1 087 -3.41% | 1 464 1 087 34.64% | 1 355 1 201 12.83% | 1 187 1 419 -16.32% | 1 188 1 182 0.48% | 979 1 176 -16.68% | 1 115 1 210 -7.83% | 1 134 | 1 208 |
EPS INR | Released Forecast Spread | 11,1 9,60 15.1% | 7,97 10,4 -23.37% | 9,08 9,00 0.89% | 10,0 | 10,0 | |||||
Announcement Date | 21/10/22 | 27/01/23 | 27/04/23 | 21/07/23 | 20/10/23 | 23/01/24 | 25/04/24 | 25/07/24 | - | - |
Past sector events for Alivus Life Sciences Limited
2025-02-13 | SAWAI GROUP HOLDINGS CO., LTD.: Q3 2024 Earnings Release |
2025-02-13 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release |
2025-02-13 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
2025-02-13 07:30 am | ORGANON & CO.: Q4 2024 Earnings Release |
2025-02-13 06:40 am | RECORDATI: Q4 2024 Earnings Release |
2025-02-13 02:34 am | IPCA LABORATORIES LIMITED: Q3 2025 Earnings Release |
2025-02-13 01:00 am | IPSEN: Q4 2024 Earnings Release |
2025-02-12 | TOWA PHARMACEUTICAL CO., LTD.: Q3 2024 Earnings Release |
2025-02-12 | CAMURUS AB: Q4 2024 Earnings Release |
2025-02-12 07:03 am | SUVEN PHARMACEUTICALS LIMITED: Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALIVUS Stock
- Calendar Alivus Life Sciences Limited